Corporate News
Seres Therapeutics (NASDAQ: MCRB) Trading Overview
- Price movement: The stock closed 7.39 % lower during a 24‑hour period ending at 04:57 AM Central Europe on Saturday, 24 April 2026.
- Current price: USD 2.09 per share on major exchanges.
- Shares outstanding: 10 million.
- Market capitalization: USD 22.9 million.
- Volume in last 24 hours: USD 281.6 thousand.
- Month‑end decline: 43.8 % lower compared with the previous month.
- 200‑day simple moving average: USD 7.52.
- 52‑week range: Highest price of USD 29.98 (20 November 2025); lowest price of USD 2.02 (22 October 2026).
Performance of Peer Stocks (last 24 hours)
| Ticker | Price change | Current price | Market cap |
|---|---|---|---|
| NOMA (Nomadar) | +0.65 % | USD 1.53 | USD 27.4 million |
| PRIF-PJ (Priority Income) | 0.00 % | USD 25.08 | USD 27.3 million |
| QGLDF (Q‑gold) | 0.00 % | USD 0.13 | USD 26.9 million |
| ABVC (Abvc Biopharma) | +4.70 % | USD 1.04 | USD 26.7 million |
Company Overview
Seres Therapeutics, Inc. is a biotechnology firm headquartered in Cambridge, Massachusetts. The company focuses on developing biologic drugs that aim to restore health by repairing dysbiotic microbiomes and conducts research into metabolic diseases. It is listed on the Nasdaq stock exchange. The company completed its initial public offering on 26 June 2015. For additional information, visit the company’s website at www.serestherapeutics.com .
